Evaluating a new method for identifying pathogens and antibiotic resistance in sepsis patients
Evaluation of the Performance of the IDBIORIV Method in Pathogen Identification and Antibiotic Susceptibility Testing in Patients With Sepsis
This study is testing a new method to quickly identify germs and their resistance to antibiotics in sepsis patients to see if it can improve their treatment and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1372 (estimated) |
| Ages | 1 Day and up |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 23 sites (Bron and 22 other locations) |
| Trial ID | NCT06219135 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the IDBIORIV method for identifying pathogens and testing antibiotic susceptibility in patients diagnosed with sepsis. Sepsis is a critical condition resulting from bloodstream infections, and timely identification of the causative microorganisms is crucial for effective treatment. The study aims to assess the performance of this method compared to standard techniques used in clinical microbiology laboratories. By improving the speed and accuracy of pathogen identification, the study seeks to enhance patient outcomes and reduce mortality associated with sepsis.
Who should consider this trial
Good fit: Ideal candidates for this study are hospitalized patients of any age showing signs of infection with a confirmed positive blood culture.
Not a fit: Patients under court protection or guardianship may not benefit from this study due to eligibility restrictions.
Why it matters
Potential benefit: If successful, this method could significantly improve the speed of diagnosis and treatment for sepsis patients, potentially increasing survival rates.
How similar studies have performed: While the study employs established techniques, the specific application of the IDBIORIV method in this context is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult or child patient * Hospitalized in one of the departments registered with Hospices Civils de Lyon * Showing signs of infection * Confirmed by a 1st positive blood culture * Patient or close relative (trustworthy person or family member) or holder of parental authority who has given his or her non-objection after receiving the information note Exclusion Criteria: * Patients under court protection * Patients under guardianship or curatorship
Where this trial is running
Bron and 22 other locations
- Femme Mère enfant Hospital — Bron, France (Recruiting)
- Femme Mère Enfant Hospital — Bron, France (Recruiting)
- Femme Mère enfant Hospital — Bron, France (Not_yet_recruiting)
- Louis Pradel Hospital — Bron, France (Recruiting)
- Louis Pradel Hospital — Bron, France (Recruiting)
- Louis Pradel Hospital — Bron, France (Recruiting)
- Pierre Wertheimer Hospital — Bron, France (Recruiting)
- Edouard Herriot Hospital — Lyon, France (Recruiting)
- Edouard Herriot Hospital — Lyon, France (Recruiting)
- Edouard Herriot Hospital — Lyon, France (Not_yet_recruiting)
- Edouard Herriot Hospital — Lyon, France (Not_yet_recruiting)
- Croix Rousse Hospital — Lyon, France (Recruiting)
- Croix Rousse Hospital — Lyon, France (Not_yet_recruiting)
- Croix Rousse Hospital — Lyon, France (Recruiting)
- Croix Rousse Hospital — Lyon, France (Recruiting)
- Croix Rousse Hospital — Lyon, France (Recruiting)
- Croix Rousse Hospital — Lyon, France (Recruiting)
- Croix Rousse Hospital — Lyon, France (Not_yet_recruiting)
- Lyon Sud Hospital — Pierre-Bénite, France (Recruiting)
- Lyon Sud Hospital — Pierre-Bénite, France (Recruiting)
- Lyon Sud Hospital — Pierre-Bénite, France (Not_yet_recruiting)
- Lyon Sud Hospital — Pierre-Bénite, France (Not_yet_recruiting)
- Charpennes Hospital — Villeurbanne, France (Recruiting)
Study contacts
- Study coordinator: François VANDENESCH, Pr
- Email: francois.vandenesch@univ-lyon1.fr
- Phone: 4 72 07 11 11
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.